Capricor Therapeutics, Inc. · NASDAQ:CAPR

Litvack Frank exercised options for 3,937 Capricor Therapeutics, Inc. shares (Form 4)

Traded May 13, 2026 · Filed May 14, 2026

On May 13, 2026, Litvack Frank (Director) exercised options for 3,937 Capricor Therapeutics, Inc. shares at US$1.39 for US$5,472, leaving 133,776 shares. Filed May 14, 2026 (Form 4).

Options exercised
3,937 shares
Price
US$1.39
Value
US$5,472
Holding after
133,776 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 13, 2026Common StockOption exercise3,937US$1.39133,776Direct

Source

View original at SEC

Related